Dan talks with Axios health-care business reporter Bob Herman how Johnson & Johnson became the first drug maker to be held liable in an opioids case and how it could set the stage for the first federal opioids trial this fall in Ohio.
Go deeper: Why Johnson & Johnson's opioids verdict is both big and small